Search - tctmd.com

Displaying 161 - 180 of 378

Sort: Relevancy | Date

Presentation Miami Valves 2017

Excimer Laser Coronary Angioplasty (ELCA) 25 Years Later What Have We Learned?

Presenter: James R. Margolis

January 29, 2017

Presentation Miami Valves 2017

Case: 84 you Male with Porcine AVR 15 years ago and Moderate AR

Presenter: Zubin Agarwal

January 29, 2017

Presentation CHIP Florida 2017

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Presenter: Tanveer Rab

January 21, 2017

Presentation CHIP Florida 2017

Key Initiatives in the CHIP Space: OPTUMUM, AUC, and More

Presenter: J. Aaron Grantham

January 21, 2017

Presentation CHIP Florida 2017

The Spectrum of Acute Mechanical Circulatory Support Devices in 2017

Presenter: Navin K. Kapur

January 21, 2017

Presentation CHIP Florida 2017

Multivessel Disease and Low EF Case

Presenter: Raja Hatem

January 21, 2017

Presentation CHIP Florida 2017

Left Main Intervention: EXCEL, NOBLE and Beyond…

Presenter: Jeffrey W. Moses

January 21, 2017

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Presentation AHA 2016

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

Presentation TCT 2016

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen

October 31, 2016

Presentation TCT 2016

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone

October 31, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Presentation ESC 2016

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Presenter: Eric Velazquez

August 29, 2016

Presentation

Coronary Perforation During PCI in the United Kingdom Between 2006 and 2013

Presenter: Tim Kinnaird

August 04, 2016

Presentation

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Presenter: Mineok Chang

June 28, 2016

Presentation TVT 2016

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

Presenter: James B. Hermiller Jr

June 17, 2016

Presentation CCVVC 2016

Bypass Surgery for the Patient with Critical Limb Ischemia:Where are we in 2016?

Presenter: Danielle R Bajakian

June 15, 2016

Presentation SOLACI 2016

Left-Main Disease: When is PCI the Preferred Strategy?

Presenter: Rafael Cavalcante

June 08, 2016

Presentation

CABG and PCI in Patients With Unprotected Left Main Coronary Artery Disease

Presenter: Zhe Zheng

June 08, 2016

Presentation

Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI

Presenter: Ambarish Pandey

May 12, 2016

Advertisement

Excimer Laser Coronary Angioplasty (ELCA) 25 Years Later What Have We Learned?

Case: 84 you Male with Porcine AVR 15 years ago and Moderate AR

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Key Initiatives in the CHIP Space: OPTUMUM, AUC, and More

The Spectrum of Acute Mechanical Circulatory Support Devices in 2017

Multivessel Disease and Low EF Case

Left Main Intervention: EXCEL, NOBLE and Beyond…

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Arterial Revascularization Trial (ART)

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Coronary Perforation During PCI in the United Kingdom Between 2006 and 2013

Long-term Mortality After Revascularization in Nondiabetic Patients With Multivessel Disease

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

Bypass Surgery for the Patient with Critical Limb Ischemia:Where are we in 2016?

Left-Main Disease: When is PCI the Preferred Strategy?

CABG and PCI in Patients With Unprotected Left Main Coronary Artery Disease

Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content